Surveillance and early diagnosis of hepatocellular carcinoma

Digestive and Liver Disease

Volumn 42, Issue SUPPL. 3, 2010, Pages S223-S227

  Lencioni, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Hepatocellular carcinoma, diagnosis; Hepatocellular carcinoma, staging; Hepatocellular carcinoma, surveillance

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER STAGING; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER NODULE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; ADULT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEALTH SURVEY; HEPATITIS B; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; EARLY DIAGNOSIS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POPULATION SURVEILLANCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953708568     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(10)60509-9     Document Type: Article

References (26)

1. Llovet JM, Burroughs A, Bruix J Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
2. Lencioni R, Cioni D, Delia Pina C, et al. Imaging diagnosis. Semin Liver Dis 2005, 25:162-170.
3. Lencioni R, Crocetti L, Delia Pina MC, et al. Guidelines for imaging focal lesions in liver cirrhosis. Expert Rev Gastroenterol Hepatol 2008, 2:697-703.
4. Braix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-430.
5. Bruix J, Sherman M Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
6. Zhang BH, Yang BH, Tang ZY Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130:417-422.
7. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000, 32:842-846.
8. Wong LL, Limm WM, Severino R, et al. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000, 6:320-325.
9. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut 2001, 48:251-259.
10. Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20:65-71.
11. Sherman M Alphafetoprotein: An obituary. J Hepatol 2001, 34:603-605.
12. Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum alphafetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001, 34:570-575.
13. Oka H, Tamori A, Kuroki T, et al. Prospective study of alphafetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994, 19:61-66.
14. Marrero JA, Su GL, Wei W, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003, 37:1114-1121.
15. Lencioni R, Piscaglia F, Bolondi L Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 2008, 48:848-857.
16. Kojiro M, Roskams T Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005, 25:133-142.
17. Stigliano R, Marelli L, Yu D, et al. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome?. Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007, 33:437-447.
18. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the non-invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2007, 47:97-104.
19. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27.
20. Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010, 59(5):638-644.
21. Llovet JM, Chen Y, Wurmbach E, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006, 131:1758-1767.
22. Bennett GL, Krinsky GA, Abitbol RJ, et al. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver expiant pathology in 200 patients. AJR Am J Roentgenol 2002, 179:75-80.
23. Liu WC, Lim JH, Park CK, et al. Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol 2003, 13:1693-1698.
24. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006, 101:513-523.
25. Burrel M, Llovet JM, Ayuso C, et al. Barcelona Clinic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an expiant correlation. Hepatology 2003, 38:1034-1042.
26. Llovet JM, Di Bisceglie AM, Bruix J, et al. Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Nati Cancer Inst 2008, 100:698-711.